CA19-9/Sialyl Lewisa (GI Tumor Marker) Antibody, IgM, Clone: [121SLE], Mouse, Monoclonal

Artikelnummer: NBT-MSM1-25-P1BX
Artikelname: CA19-9/Sialyl Lewisa (GI Tumor Marker) Antibody, IgM, Clone: [121SLE], Mouse, Monoclonal
Artikelnummer: NBT-MSM1-25-P1BX
Hersteller Artikelnummer: MSM1-25-P1BX
Alternativnummer: NBT-MSM1-25-P1BX-100
Hersteller: NeoBiotechnologies
Wirt: Mouse
Kategorie: Antikörper
Applikation: IHC
Spezies Reaktivität: Human
Immunogen: Precipitin lines obtained after immuno-diffusion using MAb 116-NS-19-9 and mucins isolated from an ovarian cyst of a Lewis A+B- patient (0Le).
Alternative Synonym: CA19.9, Ovarian tumor antigen, Pancreatic tumor antigen, Sialyl Lewis a
CA19-9, a carbohydrate epitope expressed on a high MW (400kDa) mucin glycoprotein, is a sialyl Lewisa structure which is synthesized from type 1 blood group precursor chains and is present in individuals expressing the Lewisa and/or Lewisb blood group an
Klonalität: Monoclonal
Klon-Bezeichnung: [121SLE]
Molekulargewicht: >400kDa
Isotyp: IgM
NCBI: Not Known
Formulierung: 200ug/ml of Ab Purified from Bioreactor Concentrate. Prepared in 10mM PBS with 0.05% BSA & 0.05% azide. Also available WITHOUT BSA at 1.0mg/ml.
Antibody Type: Monoclonal Antibody
Anwendungsbeschreibung: Immunohistochemistry (Formalin-fixed) (1-2ug/ml for 30 minutes at RT)(Staining of formalin-fixed tissues requires heating tissue sections in 10mM Tris with 1mM EDTA, pH 9.0, for 45 min at 95C followed by cooling at RT for 20 minutes), Optimal dilution f